These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3476204)

  • 1. Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia.
    Decker RW; Ho WG; Champlin RE
    Cancer Treat Rep; 1987 Sep; 71(9):881-2. PubMed ID: 3476204
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute myeloid leukemia with amsacrine and high-dose cytosine arabinoside: a phase II trial].
    Marit G; David B; Reiffers J; Broustet A
    Bull Cancer; 1985; 72(1):37-41. PubMed ID: 3857082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study.
    Vogler WR; Preisler HD; Winton EF; Gottlieb AJ; Goldberg J; Brennan J; Grunwald H; Rai K; Browman G; Miller KB
    Cancer Treat Rep; 1986 Apr; 70(4):455-9. PubMed ID: 3516395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome.
    Estey EH; Kantarjian H; Keating M
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):1-5. PubMed ID: 8290966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
    Sung WJ; Kim DH; Sohn SK; Kim JG; Baek JH; Jeon SB; Moon JH; Ahn BM; Lee KB
    Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysis.
    Kessler T; Mohr M; Müller-Tidow C; Krug U; Brunnberg U; Mohr B; Schliemann C; Sauerland C; Serve H; Büchner T; Berdel WE; Mesters RM
    Leuk Res; 2008 Mar; 32(3):491-4. PubMed ID: 17675230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].
    Robak T; Krykowski E; Matusewicz W; Brodowski L; Hołub A; Drzewoski J
    Pol Tyg Lek; 1988 Nov; 43(47):1508-11. PubMed ID: 3075284
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.
    Keating MJ; Estey E; Kantarjian H; Plunkett W; O'Brien S; Koller C; Beran M; Freireich EJ
    Leukemia; 1992; 6 Suppl 2():78-80. PubMed ID: 1578950
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction chemotherapy for acute myelogenous leukemia.
    Kalaycio M
    Curr Hematol Rep; 2005 Jan; 4(1):49-50. PubMed ID: 15610659
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of blast crisis of chronic myelogenous leukemia with vincristine, prednisone, and cytarabine.
    Cervantes F; Rozman C; Bladé J; Montserrat E; Grañena A
    Cancer Treat Rep; 1985; 69(7-8):923-4. PubMed ID: 3860299
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early phase II study of Idarubicin combined with cytarabine in acute myelogenous leukemia. Idarubicin Study Group].
    Ogawa M; Masaoka T; Yamada K; Kimura K
    Gan To Kagaku Ryoho; 1993 May; 20(7):907-14. PubMed ID: 8489297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amsacrine with high-dose cytarabine in acute leukemia.
    Zittoun R; Bury J; Stryckmans P; Lowenberg B; Peetermans M; Rozendaal KY; Haanen C; Kerkhofs M; Jehn U; Willemze R
    Cancer Treat Rep; 1985 Dec; 69(12):1447-8. PubMed ID: 3841026
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute leukemia with amsacrine and high-dose cytarabine.
    Arlin ZA; Gaddipati J; Ahmed T; Mittelman A; Friedland M; Rieber E
    Cancer Treat Rep; 1985 Sep; 69(9):1001-2. PubMed ID: 3839713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose cytarabine in acute myelogenous leukemia.
    Zittoun R
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():38-42. PubMed ID: 2653516
    [No Abstract]   [Full Text] [Related]  

  • 15. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.
    Sitar DS; Aoki FY; Bow EJ
    J Clin Pharmacol; 2008 Aug; 48(8):995-8. PubMed ID: 18495946
    [No Abstract]   [Full Text] [Related]  

  • 16. A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia.
    Arlin ZA; Ahmed T; Mittelman A; Feldman E; Mehta R; Weinstein P; Rieber E; Sullivan P; Baskind P
    J Clin Oncol; 1987 Mar; 5(3):371-5. PubMed ID: 3546613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose busulfan and amsacrine with autologous bone marrow rescue in patients with acute myeloid leukemia in first remission.
    Huijgens PC; Ossenkoppele GJ; van der Weide M; Wijngaarden MJ; Reijneke RM; Wijermans PW; Langenhuijsen MM
    Cancer Treat Rep; 1987 May; 71(5):552-3. PubMed ID: 3471331
    [No Abstract]   [Full Text] [Related]  

  • 18. A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia.
    Giles FJ; Cortes JE; Kantarjian HM; O'Brien SM; Estey E; Beran M
    Leuk Res; 2004 Apr; 28(4):353-7. PubMed ID: 15109534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of an induction combination regimen including fractionated anthracycline.
    Krieger O; Bernhart M; Fiedler E; Kasparu H; Weber E; Lutz D
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():66. PubMed ID: 2627610
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
    Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F
    Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.